Stock Price
7.10
Daily Change
-0.60 -7.79%
Monthly
42.57%
Yearly
91.89%
Q2 Forecast
7.57

Silence Therapeutics reported $185.47K in Gross Profit on Sales for its fiscal quarter ending in June of 2025.





Gross Profit On Sales Change Date
AstraZeneca USD 12.39B 5M Dec/2025
Autolus Therapeutics Ltd USD -7.45M 3.93M Sep/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Novartis USD 10.25B 570M Dec/2025
Roche Holding CHF 22.09B 10.04B Dec/2025
Silence Therapeutics USD 185.47K 1.82M Jun/2025